Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Covid19 Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04659239
What this trial is testing

The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

Who this might be right for
COVID-19
Chinese Academy of Medical Sciences 34,020
Not applicableStudy completedNCT05621239
What this trial is testing

Understand is the COVID-19 Vaccine BNT162b2 is Safe in Indonesia People

Who this might be right for
COVID-19
Pfizer 260
Early research (Phase 1)UnknownNCT05839236
What this trial is testing

COVID-19 Vaccination Detoxification in LDL-C

Who this might be right for
COVID-19 Stress SyndromeCOVID-19 Vaccine Adverse ReactionCOVID-19-Associated Thromboembolism+3 more
Yang I. Pachankis 1
Post-approval studies (Phase 4)Study completedNCT05343871
What this trial is testing

Immunogenicity and Safety of Fractional Booster Dose of COVID-19 Vaccines Available for Use in Pakistan/Brazil: A Phase 4 Dose-optimizing Trial

Who this might be right for
COVID-19
Albert B. Sabin Vaccine Institute 2,354
Early research (Phase 1)Looking for participantsNCT06355232
What this trial is testing

Covid-19 and Influenza Oral Vaccine Study

Who this might be right for
covid19 InfectionInfluenza, Human
Vaxine Pty Ltd 100
Large-scale testing (Phase 3)Study completedNCT05567471
What this trial is testing

Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose

Who this might be right for
COVID-19 Respiratory Infection
Bharat Biotech International Limited 875
Not applicableStudy completedNCT05244330
What this trial is testing

Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2)

Who this might be right for
SARS CoV 2 Infection
First Affiliated Hospital Xi'an Jiaotong University 1,500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06672055
What this trial is testing

Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

Who this might be right for
SARS-CoV2COVID-19
Vaxart 5,485
Testing effectiveness (Phase 2)Study completedNCT06683352
What this trial is testing

Learn About Flu and COVID-19 Vaccine Responses in Healthy People

Who this might be right for
Influenza,HumanCOVID-19
BioNTech SE 1,353
Large-scale testing (Phase 3)Study completedNCT05398848
What this trial is testing

Efficacy, Safety and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell)(Recov)

Who this might be right for
COVID-19
Jiangsu Rec-Biotechnology Co., Ltd. 7,623
Post-approval studies (Phase 4)Study completedNCT05030974
What this trial is testing

RECOVAC Repeated Vaccination Study

Who this might be right for
Covid19Kidney DiseasesVaccine Response Impaired+1 more
University Medical Center Groningen 336
Not applicableActive Not RecruitingNCT04852289
What this trial is testing

A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans

Who this might be right for
COVID-19
National Institute on Aging (NIA) 78
Testing effectiveness (Phase 2)Study completedNCT04527081
What this trial is testing

Study of COVID-19 DNA Vaccine (AG0302-COVID19)

Who this might be right for
COVID-19
AnGes, Inc. 30
Large-scale testing (Phase 3)UnknownNCT04564716
What this trial is testing

Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus

Who this might be right for
Covid19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 100
Testing effectiveness (Phase 2)Looking for participantsNCT06599658
What this trial is testing

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

Who this might be right for
COVID 19InfluenzaRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 660
Large-scale testing (Phase 3)Study completedNCT05077176
What this trial is testing

Phase 3 Booster Vaccination Against COVID-19

Who this might be right for
COVID-19Sars-CoV-2 Infection
Health Institutes of Turkey 4,340
Early research (Phase 1)Study completedNCT04776317
What this trial is testing

Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 81
Testing effectiveness (Phase 2)Ended earlyNCT05788185
What this trial is testing

Safety & Immunogenicity of RVM-V001/RVM-V002 or RVMV001+RVMV002 (Co Administered as Separate Injections) in Healthy Individuals

Who this might be right for
Infectious DiseaseCOVID-19
RVAC Medicines (US), Inc. 24
Early research (Phase 1)Study completedNCT04405908
What this trial is testing

SCB-2019 as COVID-19 Vaccine

Who this might be right for
COVID-19
Clover Biopharmaceuticals AUS Pty 166
Testing effectiveness (Phase 2)Study completedNCT06695117
What this trial is testing

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older

Who this might be right for
COVID-19 ImmunizationInfluenza Immunization
Sanofi 980
Next Page